Edition:
United States

Profile: InterCure Ltd (INCR.TA)

INCR.TA on Tel Aviv Stock Exchange

790.10ILa
10:23am EDT
Change (% chg)

-17.00 (-2.11%)
Prev Close
807.10
Open
810.00
Day's High
847.50
Day's Low
783.50
Volume
664,814
Avg. Vol
849,887
52-wk High
1,420.00
52-wk Low
60.10

InterCure Ltd is an Israel-based medical device company. It is engaged in the production and sale of RESPeRATE, a Food and Drug Administration approved, non-drug, non-invasive hypertension treatment device. The Company’s patented device-guided breathing platform is used by RESPeRATE, and it enables a systematic reduction in sympathetic outflow of the autonomous nervous system, one of the key underlining causes for cardiovascular disease, insomnia and multiple other conditions. The Company operates a marketing office in London and outsourced call centers and warehouses in the United States, the United Kingdom, Germany and Canada.

Company Address

InterCure Ltd

OSISHKIN 11
HADERA     3844346
P: +9727.32207002
F: +9729.7680244

Company Web Links